Michael R. Harrison - Concepedia

Author

Michael R. Harrison

Also Known As

Harrison, Harrison, Michael R., Harrison, Mike, M Harrison, M J G Harrison, M J Harrison, M R Harrison, M. Harrison, M.J.G. Harrison, M.R. Harrison

295

Publications

11.7K

Citations

H-Index

143

Concepts

All Affiliations

Duke Medical Center Duke Cancer Institute Duke University University of California, San Francisco Memorial Sloan Kettering Cancer Center

About

Michael R. Harrison is an author at Duke Medical Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	66	5.5K
2	Health Sciences	10	10	269
3	Public Health	10	10	531
4	Education	2	2	44
5	Engineering	1	1	27

Michael R. Harrison

107

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial Robert J. Motzer, Brian I. Rini, David F. McDermott, Journal of Clinical Oncology	2014	1.1K
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial Alison Halliday, Michael R. Harrison, Elizabeth Hayter, The Lancet Carotid Artery SurgeryCardiovascular Disease10-Year Stroke PreventionMedicineEndovascular Technique	2010	910
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial Robert J. Motzer, Brian I. Rini, David F. McDermott, The Lancet Oncology UrologyGenitourinary CancerMedicinePharmacologyImmune Checkpoint Inhibitor	2019	763
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, The Lancet Oncology First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine	2021	627
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network	2017	573
Plug the lung until it grows (PLUG): A new method to treat congenital diaphragmatic hernia in utero Marc H. Hedrick, James M. Estes, Kerry M. Sullivan, Journal of Pediatric Surgery Interventional PulmonologyHernia SurgeryCongenital Diaphragmatic HerniaPediatricsThoracic Surgery	1994	314
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma Toni K. Choueiri, Mayer Fishman, Bernard Escudier, Clinical Cancer Research	2016	290
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020 Robert J. Motzer, Eric Jonasch, M. Dror Michaelson, Journal of the National Comprehensive Cancer Network	2019	289
Primary fetal hydrothorax: Natural history and management Michael T. Longaker, Jean‐Martin Laberge, Jean Dansereau, Journal of Pediatric Surgery Fetal MedicineGynecologyPrimary Fetal HydrothoraxAnatomyFetal Complication	1989	259
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial Evan Y. Yu, Daniel P. Petrylak, Peter H. O’Donnell, The Lancet Oncology UrologyPd-l1 InhibitorsGenitourinary CancerMedicineEnfortumab Vedotin	2021	250

Page 1